3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Discovery of novel 5-oxa-2,6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Bioorganic & Medicinal Chemistry
          Bioorganic & Medicinal Chemistry
          Elsevier BV
          09680896
          August 2017
          August 2017
          : 25
          : 15
          : 4175-4193
          Article
          10.1016/j.bmc.2017.06.007
          68d2ddd4-92a8-4b25-aab5-1c515d827c68
          © 2017

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article